-
Mashup Score: 0Telix Announces Positive Topline Results of ZIRCON Phase III Kidney Cancer Imaging Study - Telix Pharmaceuticals | Telix Pharmaceuticals - 2 year(s) ago
Our mission is to help patients with cancer live longer with better quality lives
Source: Telix PharmaceuticalsCategories: Latest Headlines, Oncologists2Tweet
-
Mashup Score: 0Telix Announces Positive Topline Results of ZIRCON Phase III Kidney Cancer Imaging Study - Telix Pharmaceuticals | Telix Pharmaceuticals - 2 year(s) ago
Our mission is to help patients with cancer live longer with better quality lives
Source: Telix PharmaceuticalsCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1Telix Announces Positive Topline Results of ZIRCON Phase III Kidney Cancer Imaging Study - Telix Pharmaceuticals | Telix Pharmaceuticals - 2 year(s) ago
Our mission is to help patients with cancer live longer with better quality lives
Source: Telix PharmaceuticalsCategories: Hem/Oncs, Latest HeadlinesTweet-
Just in: Positive ph3 Zircon imaging study👉@telixpharma CA-9 PET/CT scan has 86% sensitivity & 87% specificity in detecting clear cell RCC non-invasively. Press release👉https://t.co/Ep3OHvhzPP Congrats Brian @KidneyCancerDoc #ColinHyaward @OncoAlert @kidneycan @KidneyCancer https://t.co/FArNWxXmi6 https://t.co/XZp3n9Jtej
-
-
Mashup Score: 0Telix Announces Positive Topline Results of ZIRCON Phase III Kidney Cancer Imaging Study - Telix Pharmaceuticals | Telix Pharmaceuticals - 2 year(s) ago
Our mission is to help patients with cancer live longer with better quality lives
Source: Telix PharmaceuticalsCategories: Latest Headlines, UrologyTweet
Amazing news, after many years and efforts CAIX becomes a reality! Can’t wait to see innovative trials design with it incorporation! Here’s the link btw https://t.co/I8VfpBd29c https://t.co/x6qdqAnuxB